PRECLINICAL ADDICTION RESEARCH CONSORTIUM ON THE NEUROBIOLOGY AND EXPERIMENTAL THERAPEUTICS OF ADDICTION
Knowledge Changing Therapeutics
The Preclinical Addiction Research Consortium (PARC) was created to facilitate the discovery of neurobiological mechanisms of addiction and accelerate the development of experimental therapeutics for the treatment of alcohol, tobacco, and substance use disorders.
We are located in the Department of Psychiatry at the University of California, San Diego, School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences. The PARC is strategically positioned to leverage the outstanding scientific environment of UCSD.
WHO ARE WE?
The PARC comprises experts in molecular biology, cellular physiology, neuroanatomy, and experimental psychology who use state-of-the-art animal models of drug use, drug dependenc,e and drug addiction to advance knowledge and novel therapeutic approaches.
PARC investigators are non-profit researchers who are dedicated to science. Our research is funded by the National Institutes of Health, State of California, and private contracts from pharmaceutical companies.
WHAT DO WE DO?
​
Below is a list of some of our current research projects, activities, and services.
Whether you are interested in discovering the biological mechanisms of drug addiction or developing new therapeutic approaches, the PARC is a unique group of researchers who work collaboratively on basic research, proof-of-concept studies, and pre-IND studies to develop small-molecule, biological, and device-based therapeutics.
SUPPORT US
Help Us Help Others
The Preclinical Addiction Research Consortium relies heavily on the generosity of others who give their time or contribute financially. Your donation will be used to help improve our knowledge of addiction, increase outreach to the local community, and facilitate the development of novel experimental therapeutics. Get in touch with us to find out about all the ways you can contribute and support our cause.
